| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |